1.

The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice.

1.

Changes in cannabis potency and first-time admissions to drug treatment:a 16-year study in the Netherlands

1.

Practical value of anti-xa activity in the evaluation of extracorporeal circuit anticoagulation during haemodialysis:Results of a cross-sectional single-centre study

2.

Practical value of anti-xa activity in the evaluation of extracorporeal circuit anticoagulation during haemodialysis:Results of a cross-sectional single-centre study

3.

Practical value of anti-xa activity in the evaluation of extracorporeal circuit anticoagulation during haemodialysis:Results of a cross-sectional single-centre study

1.

Pre-hospital management of acute coronary syndrome patients in Belgium and Luxembourg and other Western European countries.

2.

Pre-hospital management of acute coronary syndrome patients in Belgium and Luxembourg and other Western European countries.

3.

Pre-hospital management of acute coronary syndrome patients in Belgium and Luxembourg and other Western European countries.

4.

Pre-hospital management of acute coronary syndrome patients in Belgium and Luxembourg and other Western European countries.

5.

Pre-hospital management of acute coronary syndrome patients in Belgium and Luxembourg and other Western European countries.

6.

Pre-hospital management of acute coronary syndrome patients in Belgium and Luxembourg and other Western European countries.

7.

Pre-hospital management of acute coronary syndrome patients in Belgium and Luxembourg and other Western European countries.

8.

Pre-hospital management of acute coronary syndrome patients in Belgium and Luxembourg and other Western European countries.

9.

Pre-hospital management of acute coronary syndrome patients in Belgium and Luxembourg and other Western European countries.

1.

Improving somatic health for outpatients with severe mental illness: the development of an intervention

1.

Pancytopénie néonatale bovine : penser aux traitements administrés à la mère

2.

Pancytopénie néonatale bovine : penser aux traitements administrés à la mère

3.

Pancytopénie néonatale bovine : penser aux traitements administrés à la mère

4.

Pancytopénie néonatale bovine : penser aux traitements administrés à la mère

5.

Pancytopénie néonatale bovine : penser aux traitements administrés à la mère

6.

Pancytopénie néonatale bovine : penser aux traitements administrés à la mère

7.

Pancytopénie néonatale bovine : penser aux traitements administrés à la mère

8.

Pancytopénie néonatale bovine : penser aux traitements administrés à la mère

9.

Pancytopénie néonatale bovine : penser aux traitements administrés à la mère

1.

Updated recommendations on the use of ruxolitinib for the treatment of myelofibrosis.

2.

Updated recommendations on the use of ruxolitinib for the treatment of myelofibrosis.

3.

Updated recommendations on the use of ruxolitinib for the treatment of myelofibrosis.

1.

Diagnostic certainty, co-morbidity and medication in a primary care population with presumed airway obstruction : the DIDASCO2 study.

2.

Diagnostic certainty, co-morbidity and medication in a primary care population with presumed airway obstruction : the DIDASCO2 study.

3.

Diagnostic certainty, co-morbidity and medication in a primary care population with presumed airway obstruction : the DIDASCO2 study.

1.

Large diversity of linezolid-resistant isolates discovered in food-producing animals through linezolid selective monitoring in Belgium in 2019

2.

Large diversity of linezolid-resistant isolates discovered in food-producing animals through linezolid selective monitoring in Belgium in 2019

3.

Large diversity of linezolid-resistant isolates discovered in food-producing animals through linezolid selective monitoring in Belgium in 2019

1.

D-PhD02-5.1_PhD Final Thesis Report_LIN-RES